Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 19.99B 2.98B 2.61B 2.47B 2.25B 4.21B 286B 4.25B 29.51B 11.42B 146B 11.19B 10.95B 469B P/E 2026 *
13.5x
P/E 2027 * 11.7x
Enterprise Value 16.65B 2.48B 2.18B 2.05B 1.87B 3.5B 238B 3.54B 24.58B 9.51B 121B 9.32B 9.12B 391B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.5x
Free-Float
34.77%
Yield 2026 *
5.37%
Yield 2027 * 5.94%
1 day-2.34%
1 week-4.52%
Current month-4.88%
1 month-3.84%
3 months+18.58%
6 months+0.63%
Current year-0.40%
1 week 17.51
Extreme 17.51
18.64
1 month 17.41
Extreme 17.41
18.92
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 07/08/2016
Chairman 59 15/07/2013
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.34%-4.52%+2.57%-30.63% 2.98B
-2.01%-3.31%-45.61%-12.41% 14.26B
-0.10%-0.26%-18.18%-6.26% 6.3B
0.00%-7.83%-54.51%-38.98% 5.82B
-0.05%-3.07%-11.04%-25.61% 3.99B
+0.11%+0.94%-19.48%-35.62% 3.17B
-0.48%+3.36%-40.59%-17.59% 3.02B
-1.39%-8.40%+58.44% - 2.61B
+2.38%-0.19%-28.45%-11.18% 2.32B
+0.78%+2.38%+86.91%+141.05% 1.58B
Average -0.31%-2.08%-6.99%-4.14% 4.61B
Weighted average by Cap. -0.75%-2.73%-23.43%-13.93%

Financials

2026 *2027 *
Net sales 29.54B 4.41B 3.86B 3.64B 3.32B 6.22B 422B 6.28B 43.61B 16.88B 215B 16.54B 16.18B 693B 32.52B 4.85B 4.25B 4.01B 3.66B 6.85B 465B 6.91B 48.02B 18.59B 237B 18.21B 17.82B 763B
Net income 1.49B 222M 194M 183M 167M 313M 21.24B 316M 2.19B 849M 10.83B 832M 814M 34.88B 1.71B 255M 224M 211M 192M 360M 24.46B 364M 2.53B 978M 12.48B 958M 938M 40.17B
Net Debt -3.34B -498M -437M -412M -376M -703M -47.73B -710M -4.93B -1.91B -24.35B -1.87B -1.83B -78.41B -3.76B -561M -492M -464M -423M -792M -53.74B -800M -5.55B -2.15B -27.42B -2.11B -2.06B -88.28B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
24/09/26 CN¥17.55 -2.34% 7,448,269
23/09/26 CN¥17.97 +1.24% 8,475,656
22/09/26 CN¥17.75 -1.11% 7,745,959
21/09/26 CN¥17.95 -2.34% 9,990,760
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
17.55CNY
Average target price
23.75CNY
Spread / Average Target
+35.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock